Evidence map›Paper›PMID 36082212›Full record

ArticleResearch (Washington, D.C.)2022

Single-Atomic Site Catalyst Enhanced Lateral Flow Immunoassay for Point-of-Care Detection of Herbicide.

Zhaoyuan Lyu, Shichao Ding, Peter Tieu, Lingzhe Fang, Xin Li, Tao Li, Xiaoqing Pan, Mark H Engelhard, Xiaofan Ruan, Dan Du and 2 more

Abstract read
In one paragraph

Article in Research (Washington, D.C.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. MoSNanomaterials (Basel, Switzerland) · 2026
    Article
  2. [Nanomaterial-driven Lateral Flow Immunoassay: Technological Development and Application].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Review
  3. Article
  4. Biomedical Applications of Nanozymes: An Enzymology Perspective.Angewandte Chemie (International ed. in English) · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Zhaoyuan LyuSchool of Mechanical and Material Engineering, Washington State University, Pullman, WA 99164, USA.
Shichao DingSchool of Mechanical and Material Engineering, Washington State University, Pullman, WA 99164, USA.ORCID https://orcid.org/0000-0003-3795-306X
Peter TieuDepartment of Chemistry, University of California, Irvine, Irvine, CA 92697, USA.ORCID https://orcid.org/0000-0001-8727-2313
Lingzhe FangDepartment of Chemistry and Biochemistry, Northern Illinois University, DeKalb, IL 60115, USA.ORCID https://orcid.org/0000-0001-9243-7741
Xin LiSchool of Mechanical and Material Engineering, Washington State University, Pullman, WA 99164, USA.
Tao LiDepartment of Chemistry and Biochemistry, Northern Illinois University, DeKalb, IL 60115, USA.ORCID https://orcid.org/0000-0002-4913-4486
Xiaoqing PanIrvine Materials Research Institute (IMRI), Department of Materials Science and Engineering, University of California, Irvine, Irvine, CA 92697, USA.ORCID https://orcid.org/0000-0002-0965-8568
Mark H EngelhardEnvironmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, WA 99354, USA.ORCID https://orcid.org/0000-0002-5543-0812
Xiaofan RuanSchool of Mechanical and Material Engineering, Washington State University, Pullman, WA 99164, USA.
Dan DuSchool of Mechanical and Material Engineering, Washington State University, Pullman, WA 99164, USA.ORCID https://orcid.org/0000-0003-1952-4042
Suiqiong LiDL ADV-Tech, Pullman, WA 99163, USA.ORCID https://orcid.org/0000-0003-0252-2366
Yuehe LinSchool of Mechanical and Material Engineering, Washington State University, Pullman, WA 99164, USA.ORCID https://orcid.org/0000-0003-3791-7587

Funding

Single-Atom Nanozyme Enhanced Handheld Biosensor for Measurement of Pesticide ExposuresR43ES031885 · NIEHS · DL ADV-TECH, LLC · PI LI, SUIQIONG · 2020 to 2020
$147k
NIEHS NIH HHS R43 ES031885
6 · The paper itself

Abstract

Point-of-care (POC) detection of herbicides is of great importance due to their impact on the environment and potential risks to human health. Here, we design a single-atomic site catalyst (SASC) with excellent peroxidase-like (POD-like) catalytic activity, which enhances the detection performance of corresponding lateral flow immunoassay (LFIA). The iron single-atomic site catalyst (Fe-SASC) is synthesized from hemin-doped ZIF-8, creating active sites that mimic the Fe active center coordination environment of natural enzyme and their functions. Due to its atomically dispersed iron active sites that result in maximum utilization of active metal atoms, the Fe-SASC exhibits superior POD-like activity, which has great potential to replace its natural counterparts. Also, the catalytic mechanism of Fe-SASC is systematically investigated. Utilizing its outstanding catalytic activity, the Fe-SASC is used as label to construct LFIA (Fe-SASC-LFIA) for herbicide detection. The 2,4-dichlorophenoxyacetic acid (2,4-D) is selected as a target here, since it is a commonly used herbicide as well as a biomarker for herbicide exposure evaluation. A linear detection range of 1-250 ng/mL with a low limit of detection (LOD) of 0.82 ng/mL has been achieved. Meanwhile, excellent specificity and selectivity towards 2,4-D have been obtained. The outstanding detection performance of the Fe-SASC-LFIA has also been demonstrated in the detection of human urine samples, indicating the practicability of this POC detection platform for analyzing the 2,4-D exposure level of a person. We believe this proposed Fe-SASC-LFIA has potential as a portable, rapid, and high-sensitive POC detection strategy for pesticide exposure evaluation.

Identifiers

PMID36082212
PMCPMC9435159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.